Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1321 entries
Sorted by: Best Match Show Resources per page
Recent trends in school-based mental health services among low-income and racial and ethnic minority adolescents

Minority STEM training

Cummings JR, Hu JC, Wen H, Wilk AS.
GSID: Zig39_K7JAMJ
AS Wilk, JC Hu, H Wen, JR Cummings - JAMA pediatrics, 2022 - jamanetwork.com

Methods| In this survey study, we used 2009-2019 public-use data from the National Survey on Drug Use and Health (NSDUH) to evaluate trends in self-reported receipt of any past-…

Cite
Wilk, A. S., Hu, J. C., Wen, H., & Cummings, J. R. (2022). Recent trends in school-based mental health services among low-income and racial and ethnic minority adolescents. JAMA pediatrics, 176(8), 813-815.
Wilk, Adam S., et al. "Recent trends in school-based mental health services among low-income and racial and ethnic minority adolescents." JAMA pediatrics 176.8 (2022): 813-815.
Copy Download .nbib Format: MLA
The venous drainage of the corpora cavernosa in the human penis.

Arab journal of urology

Hsu GL, Hung YP, Tsai MH, Chang HC, Liu SP, Molodysky E, Hsu MC.
PMID: 26558109
Arab J Urol. 2013 Dec;11(4):384-91. doi: 10.1016/j.aju.2013.04.002. Epub 2013 May 16.

OBJECTIVE: To study the drainage proportions from the corpora cavernosa in defrosted human cadavers, as the veins related to penile erection were recently depicted to comprise the deep dorsal vein (DDV), a pair of cavernous veins (CVs) and two...

Cite
Hsu GL, Hung YP, Tsai MH, et al. The venous drainage of the corpora cavernosa in the human penis. Arab J Urol. 2013;11(4):384-91doi: 10.1016/j.aju.2013.04.002.
Hsu, G. L., Hung, Y. P., Tsai, M. H., Chang, H. C., Liu, S. P., Molodysky, E., & Hsu, M. C. (2013). The venous drainage of the corpora cavernosa in the human penis. Arab journal of urology, 11(4), 384-91. https://doi.org/10.1016/j.aju.2013.04.002
Hsu, Geng-Long, et al. "The venous drainage of the corpora cavernosa in the human penis." Arab journal of urology vol. 11,4 (2013): 384-91. doi: https://doi.org/10.1016/j.aju.2013.04.002
Hsu GL, Hung YP, Tsai MH, Chang HC, Liu SP, Molodysky E, Hsu MC. The venous drainage of the corpora cavernosa in the human penis. Arab J Urol. 2013 Dec;11(4):384-91. doi: 10.1016/j.aju.2013.04.002. Epub 2013 May 16. PMID: 26558109; PMCID: PMC4443007.
Copy Download .nbib Format: NLM
Detect AD Patients by Using EEG Coherence Analysis.

Journal of medical engineering

Ho MC, Chen TC, Huang CF, Yu CH, Chen JM, Huang RY, Ho HC, Liu CJ.
PMID: 27006929
J Med Eng. 2014;2014:236734. doi: 10.1155/2014/236734. Epub 2014 Feb 10.

The purpose of this study is to discriminate mild Alzheimer's disease (AD) patients from the normal aging. The EEG coherence was applied to analyze the data from auditory oddball paradigm to discriminate the differences of corticocortical connections between mild...

Cite
Ho MC, Chen TC, Huang CF, et al. Detect AD Patients by Using EEG Coherence Analysis. J Med Eng. 2014;2014:236734doi: 10.1155/2014/236734.
Ho, M. C., Chen, T. C., Huang, C. F., Yu, C. H., Chen, J. M., Huang, R. Y., Ho, H. C., & Liu, C. J. (2014). Detect AD Patients by Using EEG Coherence Analysis. Journal of medical engineering, 2014236734. https://doi.org/10.1155/2014/236734
Ho, Ming-Chung, et al. "Detect AD Patients by Using EEG Coherence Analysis." Journal of medical engineering vol. 2014 (2014): 236734. doi: https://doi.org/10.1155/2014/236734
Ho MC, Chen TC, Huang CF, Yu CH, Chen JM, Huang RY, Ho HC, Liu CJ. Detect AD Patients by Using EEG Coherence Analysis. J Med Eng. 2014;2014:236734. doi: 10.1155/2014/236734. Epub 2014 Feb 10. PMID: 27006929; PMCID: PMC4782614.
Copy Download .nbib Format: NLM
Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy.

Journal of robotic surgery

Kowalczyk KJ, Huang AC, Williams SB, Yu HY, Hu JC.
PMID: 27000927
J Robot Surg. 2013 Sep;7(3):301-4. doi: 10.1007/s11701-012-0377-9. Epub 2012 Aug 19.

Robotic-assisted laparoscopic prostatectomy (RALP) has surged in popularity since US Food and Drug Administration approval in 2000. Advantages include improved visualization and increased instrument dexterity within the pelvis. Obesity and narrow pelves have been associated with increased difficulty during...

Cite
Kowalczyk KJ, Huang AC, Williams SB, et al. Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. J Robot Surg. 2012;7(3):301-4doi: 10.1007/s11701-012-0377-9.
Kowalczyk, K. J., Huang, A. C., Williams, S. B., Yu, H. Y., & Hu, J. C. (2013). Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. Journal of robotic surgery, 7(3), 301-4. https://doi.org/10.1007/s11701-012-0377-9
Kowalczyk, Keith J, et al. "Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy." Journal of robotic surgery vol. 7,3 (2013): 301-4. doi: https://doi.org/10.1007/s11701-012-0377-9
Kowalczyk KJ, Huang AC, Williams SB, Yu HY, Hu JC. Robotic-assisted laparoscopic radical prostatectomy after aborted retropubic radical prostatectomy. J Robot Surg. 2013 Sep;7(3):301-4. doi: 10.1007/s11701-012-0377-9. Epub 2012 Aug 19. PMID: 27000927.
Copy Download .nbib Format: NLM
Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes.

World journal of hepatology

Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ.
PMID: 28515846
World J Hepatol. 2017 Apr 28;9(12):603-612. doi: 10.4254/wjh.v9.i12.603.

AIM: To assess for passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts (TIPS) and compare outcomes with maximally dilated TIPS.METHODS: Polytetrafluoroethylene covered TIPS (Viatorr) from July 2002 to December 2013 were retrospectively reviewed at two hospitals in a...

Cite
Hsu MC, Weber CN, Stavropoulos SW, et al. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol. 2017;9(12):603-612doi: 10.4254/wjh.v9.i12.603.
Hsu, M. C., Weber, C. N., Stavropoulos, S. W., Clark, T. W., Trerotola, S. O., Shlansky-Goldberg, R. D., Soulen, M. C., & Nadolski, G. J. (2017). Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World journal of hepatology, 9(12), 603-612. https://doi.org/10.4254/wjh.v9.i12.603
Hsu, Michael C, et al. "Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes." World journal of hepatology vol. 9,12 (2017): 603-612. doi: https://doi.org/10.4254/wjh.v9.i12.603
Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol. 2017 Apr 28;9(12):603-612. doi: 10.4254/wjh.v9.i12.603. PMID: 28515846; PMCID: PMC5411955.
Copy Download .nbib Format: NLM
Dermal desmoplastic fibroblastoma presenting as a large sacral mass.

The Australasian journal of dermatology

Hu SC, Lin CL.
PMID: 26114246
Australas J Dermatol. 2016 Nov;57(4):296-299. doi: 10.1111/ajd.12363. Epub 2015 Jun 26.

Desmoplastic fibroblastoma (collagenous fibroma) is a rare and recently recognised benign tumour. Most desmoplastic fibroblastomas arise in the subcutaneous tissue or skeletal muscle. Involvement of the dermis is extremely rare. We describe an unusual case of dermal desmoplastic fibroblastoma...

Cite
Hu SC, Lin CL. Dermal desmoplastic fibroblastoma presenting as a large sacral mass. Australas J Dermatol. 2015;57(4):296-299doi: 10.1111/ajd.12363.
Hu, S. C., & Lin, C. L. (2016). Dermal desmoplastic fibroblastoma presenting as a large sacral mass. The Australasian journal of dermatology, 57(4), 296-299. https://doi.org/10.1111/ajd.12363
Hu, Stephen Chu-Sung, and Lin, Chi-Ling. "Dermal desmoplastic fibroblastoma presenting as a large sacral mass." The Australasian journal of dermatology vol. 57,4 (2016): 296-299. doi: https://doi.org/10.1111/ajd.12363
Hu SC, Lin CL. Dermal desmoplastic fibroblastoma presenting as a large sacral mass. Australas J Dermatol. 2016 Nov;57(4):296-299. doi: 10.1111/ajd.12363. Epub 2015 Jun 26. PMID: 26114246.
Copy Download .nbib Format: NLM
Zymomonas mobilis: a novel platform for future biorefineries.

Biotechnology for biofuels

He MX, Wu B, Qin H, Ruan ZY, Tan FR, Wang JL, Shui ZX, Dai LC, Zhu QL, Pan K, Tang XY, Wang WG, Hu QC.
PMID: 25024744
Biotechnol Biofuels. 2014 Jul 02;7:101. doi: 10.1186/1754-6834-7-101. eCollection 2014.

Biosynthesis of liquid fuels and biomass-based building block chemicals from microorganisms have been regarded as a competitive alternative route to traditional. Zymomonas mobilis possesses a number of desirable characteristics for its special Entner-Doudoroff pathway, which makes it an ideal...

Cite
He MX, Wu B, Qin H, et al. Zymomonas mobilis: a novel platform for future biorefineries. Biotechnol Biofuels. 2014;7:101doi: 10.1186/1754-6834-7-101.
He, M. X., Wu, B., Qin, H., Ruan, Z. Y., Tan, F. R., Wang, J. L., Shui, Z. X., Dai, L. C., Zhu, Q. L., Pan, K., Tang, X. Y., Wang, W. G., & Hu, Q. C. (2014). Zymomonas mobilis: a novel platform for future biorefineries. Biotechnology for biofuels, 7101. https://doi.org/10.1186/1754-6834-7-101
He, Ming Xiong, et al. "Zymomonas mobilis: a novel platform for future biorefineries." Biotechnology for biofuels vol. 7 (2014): 101. doi: https://doi.org/10.1186/1754-6834-7-101
He MX, Wu B, Qin H, Ruan ZY, Tan FR, Wang JL, Shui ZX, Dai LC, Zhu QL, Pan K, Tang XY, Wang WG, Hu QC. Zymomonas mobilis: a novel platform for future biorefineries. Biotechnol Biofuels. 2014 Jul 02;7:101. doi: 10.1186/1754-6834-7-101. eCollection 2014. PMID: 25024744; PMCID: PMC4094786.
Copy Download .nbib Format: NLM
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Frontiers in aging neuroscience

Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D.
PMID: 27303289
Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016.

No abstract available.

Cite
Lerche S, Heinzel S, Alves GW, et al. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016;8:121doi: 10.3389/fnagi.2016.00121.
Lerche, S., Heinzel, S., Alves, G. W., Barone, P., Behnke, S., Ben-Shlomo, Y., Berendse, H., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hipp, G., Hu, M. T., Kasten, M., Krüger, R., Liepelt-Scarfone, I., Maetzler, W., Moccia, M., Mollenhauer, B., Oertel, W., Roeben, B., Walter, U., Wirdefeldt, K., & Berg, D. (2016). Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in aging neuroscience, 8121. https://doi.org/10.3389/fnagi.2016.00121
Lerche, Stefanie, et al. "Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies." Frontiers in aging neuroscience vol. 8 (2016): 121. doi: https://doi.org/10.3389/fnagi.2016.00121
Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. PMID: 27303289; PMCID: PMC4882324.
Copy Download .nbib Format: NLM
Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer.

Asian Pacific journal of cancer prevention : APJCP

Lv ShP, Wang Y, Huang L, Wang F, Zhou JG, Ma H.
PMID: 28345820
Asian Pac J Cancer Prev. 2017 Feb 01;18(2):391-397. doi: 10.22034/APJCP.2017.18.2.391.

Background: The serum level of gastrin-releasing peptide precursor (proGRP) is generally. elevated in patients with small cell lung cancer (SCLC). However, the diagnostic sensitivity and specificity of serum proGRP in SCLC cases remains controversial. The study aimed to assess...

Cite
Lv ShP, Wang Y, Huang L, et al. Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2017;18(2):391-397doi: 10.22034/APJCP.2017.18.2.391.
Lv, S. h. P., Wang, Y., Huang, L., Wang, F., Zhou, J. G., & Ma, H. (2017). Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer. Asian Pacific journal of cancer prevention : APJCP, 18(2), 391-397. https://doi.org/10.22034/APJCP.2017.18.2.391
Lv, Shui Ping, et al. "Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer." Asian Pacific journal of cancer prevention : APJCP vol. 18,2 (2017): 391-397. doi: https://doi.org/10.22034/APJCP.2017.18.2.391
Lv ShP, Wang Y, Huang L, Wang F, Zhou JG, Ma H. Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2017 Feb 01;18(2):391-397. doi: 10.22034/APJCP.2017.18.2.391. PMID: 28345820; PMCID: PMC5454733.
Copy Download .nbib Format: NLM
Validation and application of the personnel factor for the garment used in cleanrooms.

Data in brief

Hu SC, Shiue A.
PMID: 26870761
Data Brief. 2016 Jan 02;6:750-7. doi: 10.1016/j.dib.2015.12.031. eCollection 2016 Mar.

The cleanroom environment has many potential sources of contamination, including: operators, equipment, structures, and any surface that can create particles via friction, heat, exhaust, outgassing, and static electricity charge. Operatives working in the cleanroom are the major source of...

Cite
Hu SC, Shiue A. Validation and application of the personnel factor for the garment used in cleanrooms. Data Brief. 2016;6:750-7doi: 10.1016/j.dib.2015.12.031.
Hu, S. C., & Shiue, A. (2016). Validation and application of the personnel factor for the garment used in cleanrooms. Data in brief, 6750-7. https://doi.org/10.1016/j.dib.2015.12.031
Hu, Shih-Cheng, and Shiue, Angus. "Validation and application of the personnel factor for the garment used in cleanrooms." Data in brief vol. 6 (2016): 750-7. doi: https://doi.org/10.1016/j.dib.2015.12.031
Hu SC, Shiue A. Validation and application of the personnel factor for the garment used in cleanrooms. Data Brief. 2016 Jan 02;6:750-7. doi: 10.1016/j.dib.2015.12.031. eCollection 2016 Mar. PMID: 26870761; PMCID: PMC4738007.
Copy Download .nbib Format: NLM
Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India

Lin SW, Chou YT, Kao KC, Chuang LP, Yang CM, Hu HC, Huang CC, Yang CT, Chen NH.
PMID: 25621259
Indian J Otolaryngol Head Neck Surg. 2015 Mar;67:79-85. doi: 10.1007/s12070-014-0777-4. Epub 2014 Sep 19.

Neurocognitive dysfunction is a major clinical consequence in patients with obstructive sleep apnea syndrome (OSAS). The effects of continuous positive airway pressure (CPAP) treatment, as the gold standard of treatment in OSAS, on this major complication are controversial. The...

Cite
Lin SW, Chou YT, Kao KC, et al. Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment. Indian J Otolaryngol Head Neck Surg. 2014;67:79-85doi: 10.1007/s12070-014-0777-4.
Lin, S. W., Chou, Y. T., Kao, K. C., Chuang, L. P., Yang, C. M., Hu, H. C., Huang, C. C., Yang, C. T., & Chen, N. H. (2015). Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 6779-85. https://doi.org/10.1007/s12070-014-0777-4
Lin, Shih-Wei, et al. "Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment." Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India vol. 67 (2015): 79-85. doi: https://doi.org/10.1007/s12070-014-0777-4
Lin SW, Chou YT, Kao KC, Chuang LP, Yang CM, Hu HC, Huang CC, Yang CT, Chen NH. Immediate and Long-term Neurocognitive Outcome in Patients with Obstructive Sleep Apnea Syndrome After Continuous Positive Airway Pressure Treatment. Indian J Otolaryngol Head Neck Surg. 2015 Mar;67:79-85. doi: 10.1007/s12070-014-0777-4. Epub 2014 Sep 19. PMID: 25621259; PMCID: PMC4298599.
Copy Download .nbib Format: NLM
Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.

Therapeutics and clinical risk management

Chang Y, Tolani B, Nie X, Zhi X, Hu M, He B.
PMID: 29066904
Ther Clin Risk Manag. 2017 Oct 11;13:1363-1374. doi: 10.2147/TCRM.S141991. eCollection 2017.

Circulating cell-free DNA (cfDNA) released by tumor cells, termed ctDNA, closely reflects the heterogeneity of primary cancers and their metastases. As a noninvasive, real-time monitoring biomarker, ctDNA is a promising tool for detecting driver gene mutations, assessing tumor burden...

Cite
Chang Y, Tolani B, Nie X, et al. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Ther Clin Risk Manag. 2017;13:1363-1374doi: 10.2147/TCRM.S141991.
Chang, Y., Tolani, B., Nie, X., Zhi, X., Hu, M., & He, B. (2017). Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Therapeutics and clinical risk management, 131363-1374. https://doi.org/10.2147/TCRM.S141991
Chang, Yi, et al. "Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring." Therapeutics and clinical risk management vol. 13 (2017): 1363-1374. doi: https://doi.org/10.2147/TCRM.S141991
Chang Y, Tolani B, Nie X, Zhi X, Hu M, He B. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Ther Clin Risk Manag. 2017 Oct 11;13:1363-1374. doi: 10.2147/TCRM.S141991. eCollection 2017. PMID: 29066904; PMCID: PMC5644666.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1321 entries